<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000617659"><TermName>diclofenac</TermName><TermPronunciation>(dy-KLOH-feh-nak)</TermPronunciation><TermDefinition><DefinitionText>The active ingredient in a drug that is used to treat the symptoms of rheumatoid arthritis and is being studied in the prevention and treatment of some types of skin cancer. It blocks substances that cause inflammation and pain. It may also prevent the growth of new blood vessels that tumors need to grow. It is a type of cyclooxygenase inhibitor, a type of nonsteroidal anti-inflammatory drug (NSAID), and a type of antiangiogenesis agent.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000723040" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;diclofenac&quot;" language="en" id="_3"/><MediaLink ref="CDR0000723041" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;diclofenaco&quot;" language="es" id="_4"/><SpanishTermName>diclofenaco</SpanishTermName><SpanishTermDefinition><DefinitionText>Ingrediente activo de un medicamento que se usa para tratar los síntomas de la artritis reumatoide y que está en estudio para la prevención y el tratamiento de algunos tipos de cáncer de la piel. Bloquea las sustancias que causan inflamación y dolor. También podría impedir la formación de  vasos sanguíneos nuevos que los tumores necesitan para crecer. Es un tipo de inhibidor de la ciclooxigenasa, un tipo de medicamento antiinflamatorio no esteroideo (AINE) y un tipo de antiangiogénico.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2008-10-15</DateFirstPublished><DateLastModified>2009-04-21</DateLastModified></GlossaryTerm>
